Related Experiment Videos

Intervening on the social determinants of cardiovascular disease and diabetes

Leandris C Liburd1, Leonard Jack, Sheree Williams

  • 1Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA. lel1@cdc.gov

Insights

Greater research into social determinants is needed to reduce chronic disease disparities in racial and ethnic communities. Addressing social, policy, and historic contexts is crucial for effective interventions against heart disease and type 2 diabetes.

Area of Science:

  • Public Health
  • Health Disparities Research
  • Social Epidemiology

Background:

  • Heart disease, cerebrovascular diseases, and type 2 diabetes are leading causes of death and disability in the U.S.
  • Racial and ethnic minority communities disproportionately experience these chronic conditions.
  • Traditional behavior change strategies show limited effectiveness in eliminating population-level health disparities.

Purpose of the Study:

  • To advocate for increased intervention research focused on the social determinants of cardiovascular disease and diabetes.
  • To call for novel research questions and designs to understand the context of health disparities.
  • To highlight successful programs addressing racial and ethnic health disparities.

Main Methods:

  • Commentary and synthesis of existing research on chronic diseases and health disparities.
  • Review of intervention strategies and their impact on social determinants.
  • Highlighting programs from the Centers for Disease Control and Prevention (CDC).

Main Results:

  • Current strategies are insufficient to eliminate health disparities.
  • Greater focus on social, policy, and historical contexts is necessary.
  • Specific CDC programs show promise in addressing these disparities.

Conclusions:

  • Intervention research must target social determinants to reverse chronic disease trends in minority communities.
  • Understanding the social and historical context is a prerequisite for developing effective interventions.
  • Continued support and evaluation of programs like REACH 2010 are vital.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...